Your browser is no longer supported. Please, upgrade your browser.
Settings
VEA Vanguard FTSE Developed Markets ETF daily Stock Chart
VEA [NYSE]
Vanguard FTSE Developed Markets ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-0.87%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-1.96%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-0.96%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.58 Perf Half Y-0.49%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year7.31%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range40.88 - 47.89 Perf YTD-0.89%
Dividend1.26 P/FCF- EPS past 5Y- ROI- 52W High-7.16% Beta-
Dividend %2.83% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low8.77% ATR0.37
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)42.34 Volatility0.59% 0.60%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.67 Prev Close44.77
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume8.33M Price44.46
Recom- SMA20-0.86% SMA50-0.99% SMA200-0.28% Volume5,549,819 Change-0.69%
Jun-14-18 06:32PM  5 Passive ETFs Soaring in Popularity on Millennials' Choice Zacks
May-17-18 11:00AM  Is iShares Edge MSCI Multifactor Intl ETF (INTF) a Hot ETF Right Now? Zacks
Apr-20-18 10:46AM  A Rapidly Growing Developed Markets ETF Benzinga
Apr-19-18 02:49PM  7 Vanguard ETFs for Buy-and-Hold Investors InvestorPlace
Apr-11-18 04:13PM  Demand For International ETFs Remains Strong Benzinga
Apr-02-18 11:26AM  Wining ETF Areas of March Zacks
Mar-23-18 08:00PM  [$$] The Municipal Route Barrons.com
Mar-22-18 10:40AM  March Madness ETF Prediction and Sweet 16 Picks Zacks
Mar-20-18 08:55AM  Short Interest Rises in Popular International, Bond ETFs Investopedia
Mar-10-18 12:01AM  [$$] Values and Profit Meet Up Barrons.com
Feb-26-18 09:50AM  Weekly ETF Roundup: International & Bond Win, US Equity Lags Zacks
Jan-25-18 05:35PM  GlaxoSmithKline Could Witness Modest Rise in Revenues in 2017 Market Realist
Jan-23-18 05:10PM  Key Updates on Novartiss Kymriah Market Realist
09:03AM  Reading the Estimates for Novartiss Alcon in 4Q17 Market Realist
Jan-12-18 07:32AM  Zelboraf Could Boost Roches Sales Growth in 2018 Market Realist
Jan-11-18 07:33AM  How Is Roches Hemlibra Positioned for 2018? Market Realist
Jan-10-18 04:40PM  What to Expect from Roches Investigational Drug Polatuzumab Vedotin Market Realist
Jan-09-18 03:21PM  U.S. Listed ETFs Garner Record Inflows in 2017 Zacks
Jan-05-18 09:00AM  7 Low-Cost Vanguard ETFs to Kick-Start Your Portfolio in 2018 InvestorPlace
Dec-29-17 09:24AM  A Cheap International ETF And Its Epic Growth Spurt Benzinga
Dec-15-17 04:04PM  Despite Wall Street records, ETF investors favor foreign funds MarketWatch
Dec-14-17 10:57AM  Why ETFs Are Thriving in 2017 Zacks
Dec-09-17 12:01AM  [$$] ETF Trends to Watch in 2018 Barrons.com
Dec-06-17 10:30AM  Analysts Recommendations for GlaxoSmithKline in November 2017 Market Realist
Nov-20-17 09:32AM  5 ETFs Behind Vanguard's Success in 2017 Zacks
Nov-15-17 02:49PM  4.8 Trillion Reasons to Have a Big Shareholder Meeting, But Vanguard Draws Small Crowd The Wall Street Journal
Nov-14-17 02:36PM  7 Vanguard ETFs to Build a Total Portfolio InvestorPlace
Nov-01-17 11:03AM  Taking A Broad Approach To Japan Exposure Benzinga
Oct-27-17 07:00AM  Hedging Currency Risk Comes With Costs Morningstar
Oct-26-17 11:28AM  A Beloved, Cheap International ETF ETF Trends
08:26AM  International Exposure For Thrifty Investors Benzinga
Oct-12-17 02:45PM  Perils Of Mixing ETF Fund Families ETF.com
Oct-11-17 01:15PM  Swedroe: Non-US Valuations Attractive ETF.com
Oct-05-17 09:26AM  Investors Keep Loving This ETF Benzinga
Sep-21-17 10:31AM  Could Endowments Do Better With an All-ETF Portfolio? Barrons.com
Sep-18-17 04:07PM  How Did Novartis Perform in 1H17? Market Realist
Sep-15-17 07:00AM  One of the Most Diversified Foreign-Stock Funds Available Morningstar
Sep-13-17 07:00AM  There's Likely More Risk (and Less Reward) in Foreign Small Caps Morningstar
Sep-04-17 07:38AM  Changes in AstraZenecas Valuation after Its 2Q17 Earnings Market Realist
Sep-01-17 05:28PM  How ETF Traders Are Repositioning After August Selling ETF Trends
04:36PM  How Canadian Pacific Railways Volumes Compared to Peers Market Realist
Aug-31-17 02:06PM  How Did GlaxoSmithKlines Segments Perform in 2Q17? Market Realist
Aug-30-17 02:54PM  Behind Novartiss Valuation after 2Q17 Market Realist
Aug-28-17 03:36PM  Canadian Pacific Railway: Rise in Railcars Cover Intermodal Fall in Week 33 Market Realist
Aug-22-17 11:50AM  ETFs Pass Trading Test Every Day ETF.com
Aug-17-17 07:37AM  How Analysts View Fresenius Medical Care and Its Peers in August 2017 Market Realist
Aug-02-17 08:56AM  A Developed Markets Idea For Frugal Investors Benzinga
Aug-01-17 12:29PM  ETF Annual Inflow Record About To Be Broken ETF.com
12:16PM  July ETF Asset Scorecard Zacks
Jul-31-17 04:32PM  GlaxoSmithKlines 2Q17 Earnings Reveal Growth Market Realist
Jul-26-17 07:44AM  GlaxoSmithKline on the Street: Analyst Recommendations after 2Q17 Market Realist
Jul-25-17 12:12PM  Will Low Cost ETF Strength Make Vanguard Top Asset Manager Soon? Zacks
Jul-24-17 11:15AM  Novartis: Heres What Impacted 2Q17 Earnings and Missed Estimates Market Realist
Jul-21-17 01:44PM  What Is Vanguard's Take On Global Growth, Active-Passive Debate? Investor's Business Daily
Jul-17-17 07:39AM  How the Feds Rate Hike and Emerging Markets Correlate Market Realist
Jul-13-17 10:45AM  Nasdaq-100 ETF sees heavy inflows amid five-day rally MarketWatch
Jul-12-17 04:30PM  Dow Chemical Rises 2.8% On China-Brazil Corn M&A Barrons.com
03:16PM  Emerging Market ETFs Require Due Diligence ETF.com
Jul-10-17 02:35PM  How Sanofi Stock Performed in 2Q17 Market Realist
09:09AM  Lynparza Could Strengthen AstraZenecas Position in Womens Cancer Space Market Realist
Jul-07-17 10:09AM  How to Build a Winning ETF Portfolio for Second-Half 2017 Zacks
Jul-06-17 05:30PM  5 Most Popular ETFs of 2017 ETF Trends
Jul-05-17 12:21PM  ETF Asset Report : Developed Markets Rule in Q2 Zacks
Jul-04-17 09:07AM  Imfinzi May Be AstraZenecas Major Growth Driver Market Realist
Jun-30-17 04:51PM  Analyst Recommendations for AstraZeneca in June 2017 Market Realist
09:59AM  International ETFs Top First-Half Asset Flows Zacks
Jun-26-17 11:30AM  The Rush to Developed Markets ETFs Continues Investopedia
Jun-15-17 01:49PM  ETFs See Nearly $500B In 12 Months; Top $3T ETF.com
Jun-01-17 12:59PM  2017 ETF Inflows Surpass $200B In May ETF.com
09:08AM  GlaxoSmithKlines Vaccines Segment in 1Q17 Market Realist
May-31-17 12:40PM  ETF Asset Flow of May: Foreign Wins, U.S. Loses Zacks
May-29-17 12:35PM  AstraZenecas Revenue Continued Its Negative Trend in 1Q17 Market Realist
May-26-17 01:48PM  Fund Flows: Bonds Win, Market Conviction Weak Barrons.com
10:11AM  Inklings of Outflows From U.S. ETFs Investopedia
May-25-17 02:37PM  Global Exposure Without Leaving Home Investopedia
12:00PM  2017 ETF Inflows Are Staggering Investopedia
May-23-17 05:21PM  What To Do About Expensive US Stocks Forbes
May-22-17 10:03AM  Weekly ETF Roundup: What's Hot and Not Zacks
May-12-17 12:31PM  Cash Flow: Money Keeps Pouring Into ETFs Investopedia
May-03-17 07:36AM  Whats GlaxoSmithKlines Valuation after 1Q17 Earnings? Market Realist
May-02-17 10:24AM  Cheaper Not Always Better With ETFs Benzinga
May-01-17 01:58PM  Trump's First 100 Days: 5 Must See ETF Charts Zacks
10:28AM  ETF Asset Report for April 2017 Zacks
10:06AM  Fee Cuts Keep Coming, but This Vanguard Fund's Expense Ratio Rose Barrons.com
Apr-27-17 07:39AM  How Did Fixed Income Markets React to the First Round? Market Realist
Apr-20-17 12:00PM  An ETF Sequel Worth Talking About Investopedia
Apr-19-17 11:00AM  A Look At The Prolific Q1 ETF Asset Gatherers Benzinga
Apr-17-17 10:12AM  You may actually want to reject this investing advice from Bogle and Buffett CNBC
Apr-07-17 11:44AM  Swedroe: Following Up On 2017s Sure Things ETF.com
Apr-04-17 05:52AM  Zacks Podcast Highlights: Are U.S. Investors Focused on the Wrong Markets Right Now? Zacks
05:52AM  Zacks Podcast Highlights: Are U.S. Investors Focused on the Wrong Markets Right Now?
Apr-03-17 12:10PM  ETFs Have Record Breaking Inflows Of $135B In Q1 ETF.com
12:10PM  ETFs Have Record Breaking Inflows Of $135B In Q1
Mar-31-17 02:05PM  Consistent Performance Measurement May Improve Novartiss R&D Market Realist
02:05PM  Consistent Performance Measurement May Improve Novartiss R&D
09:05AM  Entresto Could See Steep Rise in Total Prescriptions This Year Market Realist
09:05AM  Entresto Could See Steep Rise in Total Prescriptions This Year
06:00AM  An Aggressive Retirement Saver Portfolio for ETF Investors Morningstar
06:00AM  An Aggressive Retirement Saver Portfolio for ETF Investors at Morningstar
Mar-30-17 03:13PM  Why Have Novartiss Valuation Multiples Fallen? Market Realist
The investment seeks to track the performance of the FTSE Developed All Cap ex US Index. The fund employs an indexing investment approach designed to track the performance of the FTSE Developed All Cap ex US Index, a market-capitalization-weighted index that is made up of approximately 3,790 common stocks of large-, mid-, and small-cap companies located in Canada and the major markets of Europe and the Pacific region. The adviser attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.